Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 79-101

Bentham Science Publishers

Access to resources Recommend Favorite

Combretastatin A4 phosphate: a novel vascular disrupting agent

By Nagaiah Govardhanan   Remick Scot C  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1219-1228

Future Medicine

Access to resources Recommend Favorite

Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma

By Yung Raymond   Seyfoddin Vahid   Guise Christopher   Tijono Sofian   McGregor Ailsa   Connor Bronwen   Ching Lai-Ming  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and γ-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells

By Masunaga Shin-ichiro   Nagasawa Hideko   Nagata Kenji   Suzuki Minoru   Uto Yoshihiro   Hori Hitoshi   Kinashi Yuko   Ono Koji  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 1, 2007-01 ,pp. : 47-55

Springer Publishing Company

Access to resources Recommend Favorite

Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy

By Quigley James P   Deryugina Elena I  

Future Oncology, Vol. 8, Iss. 1, 2012-01 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite